Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK120623
American Foundation for Pharmaceutical Education
Grant: Regional Award
National Institutes of Health
Grant: 1R01DK120623-01
Small molecules for expansion of islet beta-cell mass in diabetes
Howard Hughes Medical Institute
FWCI
3.53
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals